TY - JOUR
T1 - Paradoxical longevity in obese patients with intracerebral hemorrhage
AU - Kim, B. J.
AU - Lee, S. H.
AU - Ryu, W. S.
AU - Kim, C. K.
AU - Lee, J.
AU - Yoon, B. W.
N1 - Funding Information:
Study funding: Supported by the Korean Food and Drug Administration (KFDA)and the Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A060171, A080503, and A090529) . The analyses and interpretations of the data and the final content of the article were produced independent of the financial sponsors. The ABBA study was supported by the KFDA, but the KFDA has no role in the analysis of ABBA-ICH cohort.
Funding Information:
Dr. B.J. Kim reports no disclosures. Dr. S.-H. Lee has received research support from Novartis, Dong-A Pharmaceutical Co., Ltd., Sanofi-Aventis/Bristol-Myers Squibb, Daewoong Pharmaceutical Co., Ltd., Hanmi Pharmaceutical Co., Ltd., Handok Pharmaceuticals Co., Ltd., Eisai Inc., and Otsuka Pharmaceutical Co., Ltd., and the Ministry of Health and Welfare, Republic of Korea. Dr. Ryu, Dr. C.K. Kim, and Dr. JS Lee report no disclosures. Dr. Yoon serves on the editorial boards of Stroke and the Journal of Clinical Neuroscience and has received research support from the Ministry of Health and Welfare, Republic of Korea, the National Research Foundation of Korea, and Korean Food and Drug Administration.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2011/2/8
Y1 - 2011/2/8
N2 - Background: The paradoxical phenomenon of relative longevity among obese patients with established diseases has been reported for various disease conditions. The authors sought to investigate whether the obesity paradox also applies to intracerebral hemorrhage (ICH) survivors. Methods: A total of 1,604 patients with ICH from 33 centers with nationwide coverage were prospectively enrolled to this cohort between October 2002 and March 2004. Baseline information including body mass index (BMI) was collected at admission, and mortality status was ascertained from the governmental mortality archive on December 2006. Associations between obesity and 30-day mortality or long-term risk of death were analyzed. Results: Among the 1,356 patients with ICH included, the 30-day mortality rate was 7.2% and the long-term mortality rate was 26.9% after a mean follow-up of 33.6 ± 15.5 months. Neither BMI nor obesity status were associated with 30-day mortality after ICH. However, BMI was independently associated with a lower risk of long-term mortality (hazard ratio [HR] 0.91 per 1-kg/m increase; 95% confidence interval [CI] 0.87-0.95). As compared with patients of normal weight, underweight subjects had a higher risk of death (HR 1.64; 95% CI 1.11-2.40), and conversely, overweight (HR 0.69; 95% CI 0.49-0.96) or obese (HR 0.61; 95% CI 0.43-0.88) subjects showed a lower risk of post-ICH death. Conclusion: In our study, obesity was associated with a lower risk of long-term death but not with 30-day mortality after ICH. Thus, it may be considered that an obesity status in a patient with ICH be treated as an indication of metabolic reservoir capacity and an increased likelihood of survival.
AB - Background: The paradoxical phenomenon of relative longevity among obese patients with established diseases has been reported for various disease conditions. The authors sought to investigate whether the obesity paradox also applies to intracerebral hemorrhage (ICH) survivors. Methods: A total of 1,604 patients with ICH from 33 centers with nationwide coverage were prospectively enrolled to this cohort between October 2002 and March 2004. Baseline information including body mass index (BMI) was collected at admission, and mortality status was ascertained from the governmental mortality archive on December 2006. Associations between obesity and 30-day mortality or long-term risk of death were analyzed. Results: Among the 1,356 patients with ICH included, the 30-day mortality rate was 7.2% and the long-term mortality rate was 26.9% after a mean follow-up of 33.6 ± 15.5 months. Neither BMI nor obesity status were associated with 30-day mortality after ICH. However, BMI was independently associated with a lower risk of long-term mortality (hazard ratio [HR] 0.91 per 1-kg/m increase; 95% confidence interval [CI] 0.87-0.95). As compared with patients of normal weight, underweight subjects had a higher risk of death (HR 1.64; 95% CI 1.11-2.40), and conversely, overweight (HR 0.69; 95% CI 0.49-0.96) or obese (HR 0.61; 95% CI 0.43-0.88) subjects showed a lower risk of post-ICH death. Conclusion: In our study, obesity was associated with a lower risk of long-term death but not with 30-day mortality after ICH. Thus, it may be considered that an obesity status in a patient with ICH be treated as an indication of metabolic reservoir capacity and an increased likelihood of survival.
UR - http://www.scopus.com/inward/record.url?scp=79951661722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951661722&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31820b7667
DO - 10.1212/WNL.0b013e31820b7667
M3 - Article
C2 - 21228300
AN - SCOPUS:79951661722
VL - 76
SP - 567
EP - 573
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 6
ER -